Kenneth Lichtman
Psychiatry · Metuchen, NJNPI 1588857973
Payments from drug & device makers
Across 328 payments — averaging $12.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$690
- Teva Pharmaceuticals USA, Inc.$493
- Neurocrine Biosciences, Inc.$421
- Vanda Pharmaceuticals Inc.$344
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$309
- plus $745 from 9 others
What the payments were for
- Food & beverage$4,135100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 124 | $1,134 |
| Otsuka America Pharmaceutical, Inc. | 52 | $690 |
| Teva Pharmaceuticals USA, Inc. | 31 | $493 |
| Neurocrine Biosciences, Inc. | 27 | $421 |
| Vanda Pharmaceuticals Inc. | 26 | $344 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $309 |
| Sunovion Pharmaceuticals Inc. | 14 | $201 |
| Alkermes, Inc. | 10 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $152 |
| Johnson & Johnson | 7 | $113 |
| Lundbeck LLC | 3 | $40 |
| Validus Pharmaceuticals LLC | 1 | $34 |
| Bausch Health US, LLC | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$4,137 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 12 | $172,898 |
| Abilify MaintenaAripiprazole | 11 | $35,854 |
| VraylarCariprazine Hcl | 13 | $20,636 |
| TrintellixVortioxetine Hydrobromide | 12 | $5,783 |
| Aripiprazole | 47 | $2,588 |
| Clozapine | 36 | $1,354 |
| Mirtazapine | 41 | $983 |
| Clonazepam | 158 | $923 |
| Doxepin Hcl | 16 | $903 |
| Bupropion XlBupropion Hcl | 49 | $861 |
| Clomipramine Hcl | 11 | $854 |
| Duloxetine Hcl | 42 | $707 |
| Gabapentin | 32 | $700 |
| Lamotrigine | 20 | $601 |
| Quetiapine Fumarate | 37 | $572 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $493 | $172,89812 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $690 | $35,85411 claims |
| AbbVieVraylar | $1,134 | $20,63613 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $152 | $5,78312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Metuchen
- Barbara WinogradMetuchen$14K
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
- Robert BransfieldRed Bank$415K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.